Permitted daily exposure from preclinical studies of Ginkgo biloba L. dry extract

• Prif Awduron: Liliane Weber Bolfe Lamb (Awdur), Gabriela Zimmermann Prado Rodrigues (Awdur), Thalia Emmanoella Sebulsqui Saraiva (Awdur), Douglas de Souza (Awdur), Gabriel da Costa Berna (Awdur), Ana Letícia Hilário Garcia (Awdur), Fernando Bertoldi de Oliveira (Awdur), Juliana Machado Kayser (Awdur), Andriele Veiverberg (Awdur), Mariana Roza Marco (Awdur), Giulia Aline Führ (Awdur), Günther Gehlen (Awdur), Andresa Heemann Betti (Awdur), Cristiane Bastos de Mattos (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Universidade de São Paulo, 2023-11-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Resolution 658/2022 of the Brazilian Regulatory Agency requires the determination of the permitted daily exposure (PDE) of pharmaceutical agents. Ginkgo biloba L. is used therapeutically to treat memory deficits and other brain diseases. However, published results indicate that more studies...